DocuSign, a San Francisco- and Seattle-based company that provides electronic signature technology and Digital Transaction Management (DTM) services, and Herndon, Va.-based Exostar, an information technology company offering cloud-based solutions enabling secure business-to-business collaboration, will partner to allow life sciences and healthcare organizations to automate manual, paper-based processes with faster, more secure and fully-compliant all-digital document workflows.

With DocuSign’s DTM platform and eSignature solution integrated into Exostar’s Life Sciences Identity Hub, members of the Exostar community can accelerate critical business processes where documents are exchanged and completed, including clinical trial recruitment and reporting, writing and filling prescriptions.

Exostar and DocuSign help organizations of all sizes collaborate in the digital world to accelerate speed to results with:

• Increased security and compliance. Meet government, industry, and corporate regulations for privacy and security while capturing a legally binding audit trail for every transaction.
• Reduced costs. Eliminate the costs of printing, faxing, scanning and overnighting documents, physical document storage, and the manual rekeying of data from paper documents by going fully digital.
• Improved patient outcomes. Accelerate clinical trials and other R&D initiatives to bring treatments to market faster while empowering administrators, healthcare providers and patients to conveniently electronically sign anything, anytime, on any device.

“Our partnership with DocuSign lets organizations and individuals in our life science and healthcare community access DocuSign’s innovative one account, one login eSignature solution,” said Daniel Pfeifle, Exostar’s vice president of sales and marketing. “DocuSign’s solution perfectly complements the one account, one credential, single sign-on user experience of our Life Sciences Identity Hub. As a result, Exostar community members now can DocuSign documents seamlessly, securely and compliantly—anytime, anywhere, on any device—to truly unleash the power of collaboration across organizational and geographic boundaries.”

Glenn Griffin, vice president of business development, DocuSign, said, “Exostar’s Life Sciences Identity Hub is a game-changer for the industry, enabling powerful collaboration to advance research, treatment and patient care. Our joint offering will further enable organizations large and small to develop new solutions for the market while protecting sensitive information, maintain compliance and minimize cost.”

DocuSign offers bank-grade security and enterprise-grade reliability to empower businesses of all sizes to quickly, easily and securely sign, send and manage transactions in the cloud. DocuSign is the only open, independent, xDTM standards-based platform for managing all aspects of documented business transactions. DocuSign delivers industry-leading identity management, authentication, forms/data collection, collaboration, workflow automation, digital and electronic signature, payment collection and document retention in the cloud.

Exostar’s Life Sciences Identity Hub is a cloud-based solution delivered as a service. Organizations connect once, eliminating redundant infrastructure while reducing on-boarding and provisioning times from weeks or months to days.  Individuals benefit from single sign-on access, where Exostar’s Secure Access Manager (SAM) authenticates identities and enforces privileges defined by the owners of connected applications and associated documents and information. Nearly 700 life science and healthcare organizations and 15,000 individuals in 50 countries securely collaborate through Exostar’s Life Sciences Identity Hub.